🇺🇸 FDA
Patent

US 7084127

C2,5′-disubstituted and N6, C2,5′-trisubstituted adenosine derivatives and their different uses

granted A61PA61P17/02A61P25/00

Quick answer

US patent 7084127 (C2,5′-disubstituted and N6, C2,5′-trisubstituted adenosine derivatives and their different uses) held by CAN-FITE BIOPHARMA LTD. expires Mon Jul 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CAN-FITE BIOPHARMA LTD.
Grant date
Tue Aug 01 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61P, A61P17/02, A61P25/00, A61P25/04, A61P25/18